Q3 2024 · 13F-HR
72 Investment Holdings, LLCholdings as filed
Filed 2024-11-14 · accession 0000902664-24-006613
$46.5M
Reported value
7
Positions
2024-09-30
Period end
The Brief · 72 Investment Holdings, LLC · Q3 2024
AI · grounded in 13F
72 Investment Holdings, LLC reported no changes to its 13F holdings for 2024-09-30 relative to 2024-06-30.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $24.2M | 51.9% | 1,017,751 | Common | SHARED |
| 500946108 | KRRO | KORRO BIO INC | $9.3M | 19.9% | 276,831 | Common | SHARED |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $7.6M | 16.4% | 667,778 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $3.8M | 8.16% | 65,933 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $929,171 | 2.00% | 474,067 | Common | SHARED |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $430,588 | 0.93% | 352,941 | Common | SHARED |
| 90042W100 | — | TURNSTONE BIOLOGICS CORP | $306,394 | 0.66% | 549,980 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.